6 unchanged sentences
(incorporated by reference to Exhibit 3.2 to our Current Report on Form 8-K filed October 6, 2020).
−Removed: Form of Common Stock Certificate (incorporated by reference to Exhibit 4.2 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: Amended and Restated Investors’ Rights Agreement by and among the registrant and certain of its stockholders, dated as of June 2, 2020 (incorporated by reference to Exhibit 4.1 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Form of 2020 Series A Preferred Stock Warrant (incorporated by reference to Exhibit 4.3 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Form of Amendment to 2020 Series A Preferred Stock Warrants (incorporated by reference to Exhibit 4.4 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: Form of Indemnity Agreement between the registrant and its directors and officers (incorporated by reference to Exhibit 10.1 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Amended and Restated 2008 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.2 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Form of Incentive Stock Option and Option Agreement for the Amended and Restated 2008 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.3 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Amended and Restated 2018 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.4 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Form of Incentive Stock Option and Option Agreement for the Amended and Restated 2018 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.5 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.6 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: Forms of Stock Option Grant Notice, Option Agreement, RSU Award Grant Notice and Notice of Exercise for the 2020 Equity Incentive Plan (incorporated by reference to Exhibit 10.7 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: 2020 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.8 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: Offer Letter Agreement by and between the registrant and Purnanand D.
−Removed: Sarma, dated as of May 30, 2019 (incorporated by reference to Exhibit 10.9 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Description of Exhibit
−Removed: Amendment to Offer Letter Agreement by and between the registrant and Purnanand D.
−Removed: Sarma, dated as of August 5, 2020 (incorporated by reference to Exhibit 10.10 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Amended and Restated Offer Letter Agreement by and between the registrant and Michael J.
−Removed: Morin, dated as of August 5, 2020 (incorporated by reference to Exhibit 10.11 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Consulting Agreement by and between the registrant and Diane Marcou, dated as of May 1, 2020 (incorporated by reference to Exhibit 10.12 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Consulting Agreement by and between the registrant and Michael Lefenfeld, dated as of April 15, 2020 (incorporated by reference to Exhibit 10.13 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: License Agreement by and between the registrant and Arrayjet Limited, dated June 28, 2019, as amended by the Amendment to the License Agreement dated July 10, 2020 (incorporated by reference to Exhibit 10.14 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Exclusive Patent License Agreement by and between the registrant and the Massachusetts Institute of Technology as licensing agent for Whitehead Institute for Biomedical Research, dated June 25, 2009, as amended by the First Amendment to the Exclusive Patent License Agreement dated December 17, 2009, by the Second Amendment to the Exclusive Patent License Agreement Dated March 21, 2013, by the Third Amendment to the Exclusive Patent License Agreement dated August 21, 2017 and by the Fourth Amendment to the Exclusive Patent License Agreement dated July 21, 2020 (incorporated by reference to Exhibit 10.15 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Exclusive License Agreement by and between the registrant and Thomas Jefferson University, dated June 1, 2012, as amended by the First Amendment to License Agreement dated October 19, 2017 (incorporated by reference to Exhibit 10.16 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Second Amendment to License Agreement by and between the registrant and Thomas Jefferson University, dated July 28, 2020.
−Removed: Collaboration and License Agreement by and between the registrant and PH Pharma Co Ltd, dated October 15, 2019, as amended by the Amendment to the Collaboration and License Agreement dated August 13, 2020 (incorporated by reference to Exhibit 10.17 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Other Transaction Authority for Prototype Agreement by and between the registrant and the Department of Defense, United States of America, dated July 3, 2020 (incorporated by reference to Exhibit 10.18 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Second Amended and Restated Management Services Agreement, by and among the registrant, BCM Advisory Partners LLC and Broadband Capital Partners LLC, dated as of January 17, 2017, as amended by the Amendment to Second Amended and Restated Management Services Agreement dated June 12, 2018, the Second Amendment to Second Amended and Restated Management Services Agreement dated March 3, 2020 and the Third Amendment to Second Amended and Restated Management Services Agreement dated August 4, 2020 (incorporated by reference to Exhibit 10.19 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Description of Exhibit
−Removed: Series A Preferred Stock Purchase Agreement by and among the registrant and certain of its stockholders, dated as of November 18, 2015, as amended by the Amendment to Series A Preferred Stock Purchase Agreement dated December 14, 2015 (incorporated by reference to Exhibit 10.20 to our Registration Statement on Form S-1 filed on September 9, 2020).
−Removed: Offer Letter Agreement by and between the registrant and Richard F.
−Removed: Fitzgerald, dated September 18, 2020 (incorporated by reference to Exhibit 10.21 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.22 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020).
−Removed: Amended and Restated Employment Agreement by and between the registrant and Purnanand D.
−Removed: Sarma, dated September 23, 2020 (incorporated by reference to Exhibit 10.23 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020)
−Removed: Amended and Restated Employment Agreement by and between the registrant and Michael J.
−Removed: Morin, dated September 23, 2020 (incorporated by reference to Exhibit 10.24 to Amendment No.
−Removed: 1 to our Registration Statement on Form S-1/A filed on September 24, 2020)
+Added: Form of Series B Warrant (incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K filed on April 26, 2021).
+Added: Employment Letter Agreement between the Company and Corleen M.
+Added: Roche, effective April 19, 2021 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 20, 2021).
+Added: Securities Purchase Agreement by and among the Company and the Purchasers signatory thereto, dated April 26, 2021 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on April 26, 2021).
+Added: Engagement Letter, by and between the Company and Ladenburg Thalmann & Co.
+Added: Inc., dated April 9, 2021, as amended by the Amendment No.
+Added: 1 thereto, dated April 25, 2021 (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed on April 26, 2021).
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Interactive Data File (Form 10-Q for the Quarterly Period ended September 30, 2020 filed in XBRL).
+Added: Interactive Data File (Form 10-Q for the Quarterly Period ended March 31, 2021 filed in XBRL).
The financial information contained in the XBRL-related documents is "unaudited"
4 unchanged sentences
Management contracts or compensatory plans or arrangements
−Removed: Certain portions of this exhibit (indicated by asterisks) have been omitted because they are not material and would likely cause competitive harm to Immunome, Inc.
−Removed: if publicly disclosed.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
IMMUNOME, INC.
−Removed: November 16, 2020
/s/ Purnanand D.
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 16, 2020
−Removed: /s/ Richard F.
+Added: /s/ Corleen M.
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.